Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation
Journal of Pharmacy and Pharmacology · 2023
DOI: 10.1093/jpp/rgad023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Rafaela Dos Santos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sciences of Motricity Institute, Federal University of Alfenas, Alfenas, Brazil. Hauptthemen laut MEDLINE: Cannabidiol, Neuralgia, Cannabinoids, Antineoplastic Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas, National Council for the Improvement of Higher Education.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
This study aimed to investigate the effect of cannabidiol (CBD) on type 4 Toll-like receptors (TLR4), glial cells and pro-inflammatory cytokines during the neuropathic pain induced by the chemotherapy agent paclitaxel (PTX), as well as the involvement of the endocannabinoid system in this process.
Methods
Male C57BL6 mice were subjected to PTX-induced neuropathic pain. To evaluate the involvement of the TLR4, glial cells and cannabinoid CB2 receptor, specific inhibitors or antagonists were intrathecally administered. The western blotting and immunofluorescence assay was performed to evaluate the spinal expression of TLR4, microglia, astrocytes and cannabinoid CB2 receptor. The levels of spinal pro-inflammatory cytokines and endocannabinoids were determined by enzyme-linked immunosorbent assay and liquid chromatography-mass spectrometry analysis, respectively. Key findings CBD prevented PTX-induced neuropathic pain, and the cannabinoid CB2 receptor antagonist AM630 reversed this effect. In addition, CBD treatment inhibited the spinal expression of TLR4 and Iba1 in mice with neuropathic pain. CBD also increased spinal levels of endocannabinoids anandamide and 2-arachidonoylglycerol, and reduced levels of cytokines in mice with neuropathic pain.
Conclusions
CBD was efficient in preventing PTX-induced neuropathic pain, and this effect may involve inhibition of the TLR4 on microglia spinal with activation of the endocannabinoid system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sciences of Motricity Institute, Federal University of Alfenas, Alfenas, Brazil.
- Department of Pharmacology, Medical School of Ribeirão Preto, University of Sao Paulo, São Paulo, Brazil.
- Faculty of Pharmaceutical Sciences of Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
ORCID-Profile: Giovane Galdino
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas
- National Council for the Improvement of Higher Education
Zitieren
APA
Dos Santos, R., Veras, F., Netto, G., Elisei, L., Sorgi, C., Faccioli, L., & Galdino, G. (2023). Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad023
Vancouver
Dos Santos R, Veras F, Netto G, Elisei L, Sorgi C, Faccioli L, et al. Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad023
BibTeX
@article{DosSantos2023,
author = {Dos Santos, Rafaela and Veras, Flávio and Netto, Gonçalves and Elisei, Lívia and Sorgi, Carlos and Faccioli, Lúcia and Galdino, Giovane},
title = {Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation},
journal = {Journal of Pharmacy and Pharmacology},
year = {2023},
doi = {10.1093/jpp/rgad023}
}
EUVIMED